Histopathological Response of Transitional Cell Carcinoma to Arsenic Trioxide during the Treatment of Concurrently Diagnosed Acute Promyelocytic Leukaemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Histopathological Response of Transitional Cell Carcinoma to Arsenic Trioxide during the Treatment of Concurrently Diagnosed Acute Promyelocytic Leukaemia

Published:2008-12 Issue:10 Volume:20 Page:769-771
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Krishna R.,Sorour Y.,Goepel J.R.,Kirkbride P.,Smith D.J.,Ezaydi Y.,Dalley C.D.,Snowden J.A.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference5 articles.

1. Arsenic trioxide: new clinical experience with an old medication in haematological malignancies;Douer;J Clin Oncol,2005

2. Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukaemia;Estey;Blood,2006

3. Arsenic trioxide as a novel anticancer agent against human transitional carcinoma – characterising its apoptotic pathway;Pu;Anti-cancer Drugs,2002

4. Clinical trials of arsenic trioxide in haematologic and solid tumours: overview of the National Cancer Institute Cooperative Research and development studies;Murgo;Oncologist,2001

5. Overview of bladder cancer trials in the cancer and Leukaemia Group B;Small;Cancer,2003

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP